About US
Contact us
-
US committee recommends approval of GSK’s bird flu vaccineA US health regulator has recommended the approval of GlaxoSmithKline's new bird flu vaccine. The US FDA's Vaccines and Related Biological Products Advisory Committee voted unanimously that the2012/11/19
-
Bayer's $1.2B bid for vitamin maker topped by U.K. groupThe aggressive diversification campaign of Bayer CEO Marijn Dekkers has been checked, at least temporarily, by Reckitt Benckiser Group, which has moved on Schiff Nutrition International with a bid of2012/11/19
-
Catalent, Cevec in Cell Line Sales PactCatalent Pharma Solutions and Cevec Pharmaceuticals have entered a commercial cell line sales agreement for recombinant human alpha-1 antitrypsin (hAAT). The companies have also signed a joint develop2012/11/16
-
GlaxoSmithKline to pay out $90M more for Avandia claimsGlaxoSmithKline ($GSK） has shaken off more litigation tied to the safety of its Avandia diabetes drug by agreeing to pay $90 million in a settlement with 38 states. It did so without contrition. A re2012/11/16
-
AMA lines up against pharma's pay-to-delay dealsThe Federal Trade Commission has a powerful new ally in its quest to quash "pay to delay" patent settlements: The American Medical Association. As Forbes reports, the doctors' association now officia2012/11/15
-
Genzyme resolves shortage of cancer drug ThyrogenA drug shortage has been solved. Genzyme is now able to supply its thyroid cancer treatment, Thyrogen, even as it moves further into thyroid cancer treatment with a new biomarker that helps doctors d2012/11/15
-
Merck gives up on prospective Januvia-Lipitor comboJust three months after quietly snuffing its late-stage development program for the cholesterol combo MK-0524B, Merck ($MRK) has doused development efforts on a new therapy combining its diabetes dru2012/11/14
-
New drug significantly lowers bad cholesterolFor many people with high cholesterol, statins serve as the first line of treatment. However, some patients are unable to effectively reduce their low-density lipoprotein cholesterol (LDL cholester2012/11/14
-
Pharma firms choosing to run more phase-IV trialsThere has been an increase in the number of phase-IV clinical trials being initiated voluntarily by pharmaceutical companies, new research shows. Phase-IV trials are sometimes required by regulator2012/11/13
-
Takeda to acquire Envoy TherapeuticsTakeda Pharmaceutical Company's wholly-owned subsidiary, Takeda America Holdings, has entered into a definitive agreement to acquire Envoy Therapeutics and its bacTRAP drug discovery platform. The2012/11/13